Rapid manufacturing scale-ups by incumbent leaders, coupled with ongoing investments by contract manufacturers, are improving product availability and lowering cost of goods, which is critical for emerging-market penetration
114,121 Gastrointestinal autonomic neuropathy Gastrointestinal autonomic neuropathy presents with various symptoms, such as esophageal dysmotility, gastroparesis, and enteropathy, including dysphagia, gastroesophageal reflux, delayed gastric emptying, diarrhea, constipation, and fecal incontinence
One theory involves rapid weight loss associated with these medications, which can lead to structural changes in the eustachian tube, resulting in dysfunction
Ambetter's prior authorization approval rate for Ozempic in 2025 was 62% nationally per Centene's Q4 2025 investor disclosure